Clinical Trials Browser

Phase 2 × Hodgkin Disease × isatuximab × Clear all

NCT05346809 2025-06-08

Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma

Phase 2 Recruiting

LymphoidPlasma cell

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma